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Abstract
Background: Bioimpedance techniques provide a reliable method of assessing unilateral lymphedema in a
clinical setting. Bioimpedance devices are traditionally used to assess body composition at a current frequency of
50 kHz. However, these devices are not transferable to the assessment of lymphedema, as the sensitivity of
measuring the impedance of extracellular fluid is frequency dependent. It has previously been shown that the
best frequency to detect extracellular fluid is 0 kHz (or DC). However, measurement at this frequency is not
possible in practice due to the high skin impedance at DC, and an estimate is usually determined from low
frequency measurements. This study investigated the efficacy of various low frequency ranges for the detection
of lymphedema.
Methods and Results: Limb impedance was measured at 256 frequencies between 3 kHz and 1000 kHz for a
sample control population, arm lymphedema population, and leg lymphedema population. Limb impedance
was measured using the ImpediMed SFB7 and ImpediMed L-Dex U400 with equipotential electrode placement
on the wrists and ankles. The contralateral limb impedance ratio for arms and legs was used to calculate a
lymphedema index (L-Dex) at each measurement frequency. The standard deviation of the limb impedance ratio
in a healthy control population has been shown to increase with frequency for both the arm and leg. Box and
whisker plots of the spread of the control and lymphedema populations show that there exists good differen-
tiation between the arm and leg L-Dex measured for lymphedema subjects and the arm and leg L-Dex measured
for control subjects up to a frequency of about 30 kHz.
Conclusions: It can be concluded that impedance measurements above a frequency of 30 kHz decrease sensi-
tivity to extracellular fluid and are not reliable for early detection of lymphedema.
Introduction
Bioimpedance devices are rapidly gaining momentumas an adjunct in the early detection of unilateral limb
lymphedema. Lymphedema is characterized by an increase in
extracellular fluid. Traditional methods of assessment include
circumferential measurements and volume by calculation,
perometry, or Archimedes principle. However, each method
measures only the total fluid volume of the limb and is not
sensitive to changes in extracellular fluid. Bioimpedance
techniques (both single frequency and bioimpedance spec-
troscopy, BIS) can measure changes in extracellular fluid and
have been used to assess unilateral lymphedema.1,2 In this
case, the variation from ‘‘normal’’ of the ratio of the affected or
at risk limb impedance to the healthy contralateral limb im-
pedance is used to assess the degree of lymphedema present.
Bioimpedance devices measure the electrical impedance of
biological tissue in response to an applied alternating current.
The electric current will pass through different tissues de-
pendent upon the impedance to flow. Electric currents ap-
plied to the body are primarily distributed in fluids and blood,
due to the low resistivity of these tissues. In the presence of
lymphedema, the applied current will travel predominantly
through the accumulation of lymphatic fluids. This noninva-
sive and cost-effective technology can be used as a reliable
tool to assess the presence of lymphedema in patients with
either upper or lower limb affliction at an early stage.3
The electrical properties of tissue can be described by elec-
trically similar components. When current is applied to the
tissue, the extra- and intracellular fluids behave as resis-
tive components, while the cell membranes behave as reactive
components. At 0 kHz (direct current orDC) the cellmembrane
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acts as an insulator and all current flows through the extra-
cellular fluid. The impedance measured at DC (R0) is that of
extracellular fluid only. At higher current frequencies (alter-
nating current or AC), the cell membrane becomes a con-
ductor and the current will flow in both the extracellular and
intracellular fluid in a ratio that is dependent of the applied
current frequency. The impedance measured at a single fre-
quency is therefore a combination of the contribution from
extra- and intracellular fluid. As the frequency increases, there
will become a practical frequency at which the measured
impedance is no longer sensitive enough to track extracellular
fluid alone.
Due to practical limitations, R0 cannot be measured di-
rectly. However, knowledge of the frequency response of bi-
ological material allows finite frequency data to be
extrapolated to derive this value. Bioimpedance spectroscopy
(BIS) devices that use up to 256 frequency measurements to
extrapolate to the DC value have been shown to be more
sensitive to extracellular fluid changes.4 It has been shown
that R0 is most sensitive to changes in extracellular fluid
5 and
is therefore the best index of lymphedema.
It has been suggested that single frequency impedance limb
ratios and R0 limb ratios are essentially interchangeable in
assessing lymphedema as long as the current frequency re-
mains low.6 However, the same study also reports an increase
in the mean difference between the R0 and single frequency
methods and a widening of the 95% confidence interval of the
bias as the measurement frequency of the device increased.
The study does not address a specific cut-off frequency for
accurate assessment of lymphedema. The confidence interval
increases from 1.2% to 2.8% at 10 kHz to 4% to 7.1% at
50 kHz, approximately 250% increase in interval width. This
suggests that lymphedema assessments using a current fre-
quency of 50 kHz do not have adequate sensitivity. The study
also highlights the need for appropriate detection ratios for
leg lymphedema. In another study, a frequency range of
5–10 kHz has been identified as the optimum for single fre-
quency measurement of lower leg swelling due to blood
pooling.7
Many single frequency bioimpedance devices (predomi-
nantly 50 kHz) are available on the market. These devices are
traditionally used to determine body composition parame-
ters, including total body water and extracellular water of the
whole body. However, at 50 kHz, the current passes through
both intra- and extracellular fluid and so the determination of
the fluid levels are not dependant on extracellular fluid alone.
Body composition devices are also designed in most cases
to measure hand to foot impedance to determine whole body
composition using prediction equations based on population
studies. The hand to foot measurement consists of the addi-
tion of the arm, trunk, and leg impedance. Whole body water
content (measured using specific total body water apparatus
measured at 50 kHz) has been shown to be insensitive to de-
creases in circumferential and volumetric measures of an arm
during the treatment of lymphedema.8 Therefore, changes in
extracellular fluid volume in a single limb would be better
identified by a single limb measurement. Bioimpedance has
been shown to reliably measure specific body segments (arms
and legs) when the measurement electrodes are positioned on
the contralateral limb, thus using the concept of electrical
equipotentials. This approach enables accurate and repro-
ducible results.9
Therefore the aim of this study is to demonstrate the fre-
quency dependence of the precision of unilateral lymphede-
ma assessment using bioimpedance techniques and to
investigate the efficacy of various frequency ranges for the
accurate discrimination between lymphedema and control
subjects. This will lead to a more informed and reliable choice
in the selection of current frequency for the assessment of
lymphedema.
Materials and Methods
In order to determine the dependence of the assessment of
unilateral lymphedema on the current frequency used to
measure the bioelectrical impedance, the impedance of each
limb was measured at 256 frequencies. This was completed
for a control population and populations with clinically evi-
dent unilateral lymphedema in either the arm or the leg,
classified according to a criterion referenced scale modified
from that described by Miller et al.10 The data used in this
study was collected as part of three research studies con-
ducted with the Queensland University of Technology (QUT)
and the University of Queensland (UQ). Ethics approval was
obtained from the respective authoritative bodies and in-
formed consent was obtained from subjects prior to partici-
pation. Each data subset was used for analysis of one of the
three sample population groups. These were the control
population, unilateral arm lymphedema population, and
unilateral leg lymphedema population.
The limb impedance of each participant was measured
using either the ImpediMed L-Dex U400 or the ImpediMed
SFB7, according to standard measurement procedures. The L-
Dex U400 instrumentation implements the same BIS platform
utilized in the SFB7 to measure the raw bioimpedance data,
thus generating equivalent raw impedance values. The dif-
ferences between the two devices are aesthetic where the
software and user interface of the L-Dex U400 have been
specifically designed for use in assessing lymphedema in a
clinical environment. Both devices measure the impedance at
256 frequencies from 3kHz to 1000 kHz and perform regres-
sion analysis to determine R0 and R?(the theoretical resis-
tance at infinite frequency).
Limb impedance was measured using an equipotential
electrode placement on the wrists and ankles.9 The limb im-
pedance ratio was calculated for all 256 current frequencies.
For the control population, the nondominant to dominant
limb ratio was calculated. For the test populations, the unaf-
fected to affected limb ratio was calculated. The limb im-
pedance ratio was then used to determine a lymphedema
index (L-Dex), used to assess the presence of lymphedema. In
the case of SFB7 measurements, the raw impedance was
converted to an L-Dex score using proprietary software sup-
plied by the manufacturer.
The L-Dex is a quantitative indicator that represents the
comparison of the measured limb impedance ratio to a ‘nor-
mal’ range of limb impedance ratios established in a healthy
population matched for limb dominance and gender. This is
unlike body composition algorithms that use prediction
equations to determine the amount of extracellular water
content from impedance measurements. The simple lineari-
zation of the normal distribution means that measured im-
pedance ratios equal to the mean ratio of the equivalent
healthy population will have an L-Dex of 0 and those greater
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than three standard deviations from the equivalent healthy
population range will have an L-Dex greater than 10. The use
of the L-Dex for the assessment of lymphedema has been
previously reported.11,12 These studies identify the need for a
simple diagnostic scale to be used in the assessment of lym-
phedema. The use of L-Dex achieves this and allows the re-
sults to be directly compared across gender and dominance of
the affected limb on one simple scale. This avoids the need for
separate analysis to be performed for different population
characteristics (eg, female dominant arm affected) that is re-
quired when working with raw impedance ratios.
Arm lymphedema population
The sample unilateral arm lymphedema population data
was collected at the Queensland Lymphedema and Breast
Oncology Physiotherapy Clinic (UQ ethics approval No.
2007001013). Data was collected from all eligible and con-
senting patients previously diagnosedwith arm lymphedema
who attended the clinic during the study duration. Data col-
lection for patients with mild to severe unilateral arm lym-
phedema secondary to breast cancer surgery was conducted
using the ImpediMed L-Dex U400 and current clinical prac-
tice to create a dataset indicative of a sample arm lymphe-
dema test population. The demographics of the arm
lymphedema population are shown in Table 1. The imped-
ance of both arms was measured at 256 current injection fre-
quencies and the unaffected/affected arm impedance ratio
was calculated and the L-Dex recorded. The clinical charac-
teristics of the lymphedema were graded according to the
modified scale from that of Miller et al.10 and the ImpediMed
XCA. Of the 15 subjects recruited into this population group,
only data from 12 subjects were analyzed, based on the cri-
teria that at least two of the three clinical assessment methods
must confirm the presence of lymphedema at the time of as-
sessment.
Leg lymphedema population
The sample unilateral leg lymphedema population was
collected at the Queensland Lymphedema and Breast On-
cology Physiotherapy Clinic (UQ ethics approval No.
2008001030). Data was collected from all eligible and con-
senting patients previously diagnosed with leg lymphedema
who attended the clinic during the study duration. Data col-
lection for patients with mild to severe unilateral leg lym-
phedema was conducted using the ImpediMed L-Dex U400
and current clinical practice to create a dataset indicative of a
sample leg lymphedema test population. The demographics
of the leg lymphedema population are shown in Table 1. The
impedance of both legs was measured at 256 current fre-
quencies and the unaffected/affected leg impedance ratiowas
calculated and the L-Dex recorded. The clinical characteristics
of the lymphedema were graded according to the scale
modified from that of Miller et al.10 and circumferential vol-
ume differences using a tape measure. Of the 16 subjects re-
cruited into this population group, only the data from 12
subjects was analysed, based on the criteria that at least two of
the three clinical assessment methods must confirm the
presence of lymphedema at the time of data collection.
Control population
The control population data was collected at the Queens-
land University of Technology (QUT ethics approval No.
0700000853). A survey of the healthy population was con-
ducted using the ImpediMed SFB7 for the limb impedance
ratios at 256 current frequencies between 3 kHz and 1000 kHz.
Sixty-five self-diagnosed healthy females who met eligibility
criteria were recruited from the staff and student population.
The demographics of the control population are shown in
Table 1. The impedance of both arms and legs was measured
and the nondominant/dominant arm and leg impedance ra-
tio and L-Dex was calculated using the proprietary software
supplied by the manufacturer
Results and Discussion
The mean subject age was significantly higher in the test
populations than the control population ( p< 0.0001). The
difference of the mean height between each population and
the mean weight between each population was not significant
(arms: p¼ 0.1874, legs: p¼ 0.9453, and arms: p¼ 0.4472, legs:
p¼ 0.6163 for height and weight, respectively).
The arm and leg impedance ratios of the control and test
populations were calculated for each frequency between
3 kHz and 1000 kHz. The mean and standard deviation of the
impedance ratiowas also calculated at each frequency, as well
as R0 and R?. The variation of the standard deviation for the
arm and leg impedance ratios of the control population as a
function of current measurement frequency is shown in Fig-
ure 1. The standard deviation of the arm impedance ratio at
0 kHz is 0.031. This is comparable to other published exam-
ples that report the standard deviation of female arm ratios to
be 0.034.13 It is hypothesized that the lower standard devia-
tion in the present study is due to advancements in instru-
mentation technology that produces more reliable and
repeatable measurements. The 25th–75th interquartile range of
the nondominant to dominant limb impedance ratio of a
healthy control subject has also been reported as 0.994–1.057
Table 1. Population Demographics for Control, Arm Lymphedema, and Leg Lymphedema Subjects
Parameter (ms) Control Group Arm Lymphoedema Group Leg Lymphoedema Group
No. of Subjects 65 12 12
Age (years) 40.8 11.6 61.2 9.2 60.5 6.5
Height(cm) 165.1 6.3 162.7 3.1 165.0 7.1
Weight (kg) 70.5 14.6 74.0 13.8 72.7 11.5
Type of lymphedema N/A 12 Secondary 9 Secondary/3 Primary
Modified Millers Grading 4 0 10.3 2.2 9 1.7
L-Dex Score 0 3.3 44.0 37.8 24.8 14.4
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(0.063).2 This suggests a 50% distribution (in comparison to
68% for one standard deviation) of 0.0315, which is com-
parable to the standard deviation found by this current study.
There has been no standard deviation previously published
for healthy leg impedance ratios.
The standard deviation for the leg ratio is consistently
higher than for the arm ratio. This is due to better accuracy in
measuring an arm. In the case of the leg, the geometry of the
body means that often the legs cannot be separated enough to
provide adequate insulation between the thighs. As a result,
impedance measurements of the leg may contain more noise
than the arm due to this added interference.
Figure 1 clearly shows that the standard deviation of the
limb impedance ratio of a normal healthy population in-
creases as the current frequency increases for both the arm
and the leg. This is more evident in the standard deviation of
the arm ratios which increases from 3kHz. The standard de-
viation of the leg ratios begins to increase more rapidly at
20 kHz. These results indicate that the natural spread of the
measured impedance ratio within a normal population in-
creases with the measurement frequency.
The variance of the limb impedance ratio is expected to be
smallest at 0 kHz; however, this is not the case for the legs. In
the legs, the variance decreases from 0.047at 0 kHz to 0.046 at
20 kHz. Again, this may be due to inherent noise in a leg
measurement induced by the geometry of the legs. Ad-
ditionally, the nonbalanced nature of the measuring devices
results in large differences for an arm or a leg between the fit
of the raw data to a Cole model over the frequency range. This
is an interesting result and should be investigated further.
The assessment of unilateral lymphedema is performed by
comparing the measured impedance ratios for patients with
lymphedema to the average ratio and the standard spread of
the ratio collected for a normal healthy population. The L-Dex
parameter allows impedance ratios to be compared across
genders and limb dominance on the same scale and is used in
the remainder of the analysis. The agreement between
bioimpedance indices (L-Dex) and interlimb volume differ-
ences, as determined by perometry, for assessment of unilat-
eral arm lymphedema has been reported.12 Arm impedance
and volume was measured in 45 women with lymphedema
and 21 women as part of a control group without lymphe-
dema. L-Dex scores were highly correlatedwith the difference
in arm volumemeasured by perometry. Thus, L-Dex provides
a measurement index that is highly correlated (r¼ 0.926) with
quantitative measures of the volume increase in limb size seen
in lymphedema.
The L-Dex parameter uses the measured limb ratio to give
an indication of the degree of difference of the measured limb
ratio from a normal healthy population limb ratio. L-Dex
values that lie outside the normal range (-10 to 10) or that have
changedþ 10 L-Dex units from baseline may indicate early
signs of lymphedema.Due to the increase in the natural spread
of the impedance ratio in a normal population, the sensitivity
of the method is expected to decrease as the measurement
frequency increases and there becomes less clear separation
between a control subject and a lymphedema subject.
The spread of the L-Dex parameter for the control data,
along with the spread of the L-Dex parameter for the sample
lymphedema populations, is shown visually through a box
and whisker plot in Figure 2 for a collection of frequencies for
arms and legs. The L-Dex score is calculated at each frequency
for each subject as an indicator of lymphedema based on
gender and limb dominance. This allows all subjects to be
plotted on a single graph, despite these differences. The box
and whisker plot displays the sample minimum, the lower
quartile, the median, the upper quartile, and the sample
maximum of the population.
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FIG. 1. Standard deviation of impedance ratio for female arms (- -) and legs (-) as a function of current injection frequency.
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Figure 2 clearly shows that there is separation between the
control and test group at R0 for both arms and legs. This
indicates good differentiation between lymphedema subjects
and unaffected subjects for an L-Dex calculated from R0. At
about 20–30 kHz, an overlap between the upper quartile of
the normal population and the lower quartile of the affected
arm population becomes evident. This overlap increases as
the measurement frequency increases. In the case of the arms,
the overlap in impedance ratio between the population
groups is larger than for the legs. In both the arm and leg
cases, the overlap between control and test groups becomes
large enough to reduce the sensitivity of assessment above
30 kHz.
This indicates that impedance measurements above 30k
kHz are not sufficiently sensitive to extracellular fluid changes
to be used effectively to assess early stages of lymphedema
accurately. This is because the electric current will pass
through a combination of both extra- and intracellular fluids
at these frequencies. The assessment of lymphedema using
BIS has been reported14 and has shown that the extracellular
fluid volumes of the arm calculated from R0 are more sensi-
tive in determining the presence of lymphedema than total
body fluids of the arm calculated from the characteristic fre-
quency, Zc (usually around 50–80 kHz). The study showed
that the sample populations of the total fluid arm ratio for the
control group and the lymphedema group overlapped.
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FIG. 2. Box and whisker plots demonstrating the spread of L-Dex at a number of increasing frequencies for (a) control (L)
and clinically evident unilateral arm lymphedema subjects (R) and (b) control (L) and clinically evident unilateral leg
lymphedema subjects (R)
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However, clear discrimination between the two subject
groups is clearly shown for extracellular fluid ratios of the
arms. Therefore, bioimpedance devices that measure the total
fluid of a limbwill not be sensitive to changes in lymphedema.
High concordance (rc> 0.973 for frequencies below
200 kHz) has been reported6 between impedance ratios cal-
culated at a specific frequency from those calculated at R0 for
both arms and leg. However, widening of the 95% confidence
interval and an increased bias are also reported for six in-
creasing frequencies, based on Bland and Altman limits of
agreement. This previously reported method of analysis was
used with the data collected in the current study. Agreement
between the L-Dex calculated at a specific frequency and the
L-Dex calculated at R0 was determined using a Bland and
Altman analysis for each of 256 frequencies from 3kHz to
1000 kHz. A summary of the mean difference and the 95%
confidence interval as a function of frequency is shown in
Figure 3, separating the arms and legs of the control popula-
tion, the arm lymphedema population, and the leg lymphe-
dema population.
The mean difference between the L-Dex calculated from
R0 and the L-Dex calculated for each frequency for both the
arms and the legs of the control population remains constant
at close to zero for the entire frequency range. The mean
difference for both the arms and legs of the lymphedema
population is shown to increase as frequency increases (0.1
to 12 for arms and0.5 to 9 for legs over the frequency range
3 kHz–1000 kHz). This is because of the presence of fibrotic
tissue expected to be present in an established lymphedema
population such as the one used in this study. At low fre-
quencies, the measurement of impedance comprises pri-
marily extracellular fluid, while impedance measurements
made at high frequencies include interactions from the cells
and thus comprises both tissue and extracellular fluid com-
ponents. Thus the increasing difference between L-Dex at
higher frequencies and the L-Dex calculated from R0 is due
to the presence of fibrosis which is not present in a healthy
population. The bias of the mean difference at high fre-
quencies highlights the importance of using low frequency
impedance for the assessment of lymphedema in order to
detect the onset of the disease early and avoid irreversible
damage.
Each population also displays a large widening of the 95%
confidence intervals. This is larger in the lymphedema pop-
ulations. This further demonstrates that the sensitivity of the
method decreases as the current frequency increases.
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FIG. 3. Summary of Bland and Altman mean difference from L-Dex calculated from R0 (- -) and 95% confidence intervals (-)
as a function of frequency for (a) control subject arms, (b) control subject legs, (c) test lymphedema subject arms, and (d) test
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Conclusions
R0 has been shown previously as the best measurement
frequency to assess lymphedema of the arms, as it is more
accurate in measuring the extracellular water content of a
limb.3 The present study has shown that the standard devia-
tion of contralateral limb impedance ratios in a normal pop-
ulation increases as the measurement frequency increases. As
such, cut off criteria used to identify the onset of lymphedema
also increases and sensitivity is reduced.
The spread of the control L-Dex and the L-Dex calculated
for both arm and leg test subjects, has also been shown to
increase with frequency. The frequency at which an overlap
occurs between the lower quartile of the test group L-Dex and
the upper quartile of the control group L-Dex begins at about
30 kHz. This results in a decreased sensitivity for the detection
of lymphedema above this frequency.
A comparison between the L-Dex calculated at 0 kHz
and the L-Dex calculated at any non-zero single fre-
quency shows that the mean difference between the
methods remains constant over the frequency range in a
healthy population and increases in the test lymphedema
populations. This demonstrates the importance of using
low frequency impedance measurements to provide an
accurate assessment of the presence of lymphoedema and
provides further supporting evidence that the current
frequency used in bioimpedance should be below 30 kHz
to accurately assess unilateral lymphedema. The 95%
confidence interval was also shown to increase with fre-
quency for each population group. This again shows an
improved sensitivity in assessing lymphedema at low
measurement frequencies.
The many single frequency body composition devices
available on the market traditionally measure the imped-
ance at 50 kHz. This study shows that the application of
these devices to the assessment of lymphoedema is less
sensitive to extracellular fluid changes. It has been demon-
strated that changes in the extracellular fluid in unilateral
lymphedema patients (both arm and leg) can only be
monitored accurately and reliably using bioimpedance de-
vices with BIS capabilities or applied current frequencies
below 30 kHz.
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